Medication info

GCVITAD Injection (Cholecalciferol)

Prescription medicationInjectionsIntramuscular injection
Ingredient · strength
Cholecalciferol›5mg / 1mL
Manufacturer / importer
Noxibra Wellbeing Co., Ltd.
Appearance
A brown glass ampoule containing a clear, pale yellow liquid injection.
Packaging
10 ampoules/box [(1 mL/ampoule) X 10], 50 ampoules/box [(1 mL/ampoule) X 50]
Approval status
Active

MFDS item code 201504236 · Notified 2015.06.30

Summary

Main use
Prevention and treatment of vitamin D deficiency
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, adjusting the dose based on the blood 25-hydroxyvitamin D level. In adults, the therapeutic effect and tolerability should be reviewed within 3 months after administration of this drug, and the decision to readminister should be based on this review. Because adverse reactions increase with overdose, do not administer more than the required amount. - Adults: Inject 200,000IU of cholecalciferol intramuscularly. - Older adults: Inject 100,000IU of cholecalciferol intramuscularly. Do not exceed an annual total dose of 600,000IU of cholecalciferol.
Child administration
In adolescents, the therapeutic effect and tolerability should be reviewed within 6 months after administration of this drug, and the decision to readminister should be based on this review. - Adolescents: Inject 200,000IU of cholecalciferol intramuscularly.

Ingredients

Manufacturer
Noxibra Wellbeing Co., Ltd.

Efficacy & effects

Prevention and treatment of vitamin D deficiency

  • Vitamin D deficiency
View approved original text

This medication is used to prevent and treat vitamin D deficiency in the elderly, adolescents, and adults. It helps maintain bone health and supports normal calcium metabolism through adequate vitamin D intake. This is very important as it can help prevent complications such as osteoporosis. Therefore, it is effectively used for vitamin D deficiency improvement and enhancement of bone health.

How it is given

Adult administration

Use as prescribed by a physician, adjusting the dose based on the blood 25-hydroxyvitamin D level. In adults, the therapeutic effect and tolerability should be reviewed within 3 months after administration of this drug, and the decision to readminister should be based on this review. Because adverse reactions increase with overdose, do not administer more than the required amount. - Adults: Inject 200,000IU of cholecalciferol intramuscularly. - Older adults: Inject 100,000IU of cholecalciferol intramuscularly. Do not exceed an annual total dose of 600,000IU of cholecalciferol.

Child administration

In adolescents, the therapeutic effect and tolerability should be reviewed within 6 months after administration of this drug, and the decision to readminister should be based on this review. - Adolescents: Inject 200,000IU of cholecalciferol intramuscularly.

Precautions

This medication contains vitamin D, so overdose should be avoided. When taken with vitamin D fortified foods or other treatments, total vitamin D intake should be checked. Periodic testing of blood calcium levels is necessary, and if calcium levels become too high, medication should be discontinued. Special care must be taken if serum calcium levels exceed 10.5 mg/dL or urinary calcium exceeds certain standards. If calcium intake is high, regular monitoring of blood and urine calcium levels is important. When using as an injection, care must be taken to avoid glass fragments during opening, especially in children and the elderly. This medication should not be used in certain patients. Those allergic to the components, or with hypercalcemia, hypercalciuria, calcium stones, kidney disorders, patients with limited mobility, patients with specific diseases, pregnant or nursing women should not take this medication. Headaches, fatigue, muscle pain, digestive disorders, dehydration, high blood pressure, calcium stones, kidney issues, among other side effects, may occur. Immediate consultation with a doctor is necessary if unusual symptoms appear. Additionally, regular monitoring of blood vitamin D levels is important to prevent side effects due to overdose, and special caution is advised for patients with impaired kidney function. Interactions with other medications can occur, so consultation with a doctor or pharmacist is recommended when taking with anticonvulsants, certain diuretics, antacids, warfarin, etc., and regular checks of blood calcium levels and heart condition should be conducted. It is safer for pregnant and nursing women not to use this medication, and its safety and efficacy have not been established for children under 12 years. In case of overdose, vitamin D intake should be discontinued immediately, calcium intake reduced, increased fluid intake, and diuretic measures should be taken. This medication should not be mixed with other drugs, used quickly after opening, and any remaining medication should be discarded. Store it in a light-blocking container at a temperature between 1 and 25 degrees Celsius to maintain its effectiveness.

Side effects

Headache, weakness, fatigue, myalgia, anorexia, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polyuria, polydipsia, dehydration, hypertension, calcium stones, calcification of tissues such as kidneys and blood vessels, renal impairment, excess bone calcification, arrhythmia, mental symptoms, self-awareness disorder, arthralgia, myasthenia, drowsiness, azotemia, hypersensitivity reaction, thirst, confusion, gas bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria, hypercalcemia, hyperphosphatemia, hyperphosphaturia, injection site granuloma, injection site nodule, injection site reaction, injection site urticaria, injection site infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that prevents light from entering. Additionally, to maintain the drug's effectiveness, it's essential to store it at a cool temperature between 1 and 25 degrees Celsius.

Appearance and packaging

Appearance

A brown glass ampoule containing a clear, pale yellow liquid injection.

Package unit

10 ampoules/box [(1 mL/ampoule) X 10], 50 ampoules/box [(1 mL/ampoule) X 50]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.